Other disclosuresNSE · NEPHROPLUS
Nephrocare Health Services Limited
Monitoring Agency Report
01 / The disclosure
What the company shared
Pursuant to Reg 32 of SEBI LODR Regulations, 2015 read with Reg 41 of SEBI ICDR Regulations, 2018, please find enclosed Monitoring Agency Report for the quarter ended September 30, 2026.
Exchange-provided summary Company profile
A question for your research
Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.
Disclosed period ended 2026-09-30 · Q2 FY2027The evidence
Read the source excerpts
PDF text is unavailable. Read the original filing for the full disclosure.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106842711
- First collected
- 3 Nov 2026, 19:24 IST
- PDF extraction
- metadata_only
You’ve reached the end of this disclosure.